COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY

被引：1
|
作者：
Townsend, Tristan [1 ]
Razanskaite, Violeta [2 ]
Michail, Stephanie [1 ]
Morgan, James [1 ]
Davies, Michael [1 ]
Storey, Daniel [1 ]
Watters, Christopher [3 ]
Penman, Douglas [3 ]
Swaminathan, Mira [4 ]
Reilly, Ian [4 ]
Flanagan, Paul
Subramanian, Sreedhar [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[3] Arrowe Pk Hosp, Upton, England
[4] Countess Chester Hosp, Chester, Cheshire, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.237
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P162
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [31] Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
    Jose Garcia, Maria
    Rivero, Montserrat
    Fernandez-Clotet, Agnes
    de Francisco, Ruth
    Sicilia, Beatriz
    Mesonero, Francisco
    Luisa de Castro, Maria
    Jose Casanova, Maria
    Bertoletti, Federico
    Javier Garcia-Alonso, Francisco
    Lopez-Garcia, Alicia
    Vicente, Raquel
    Calvet, Xavier
    Barreiro-de Acosta, Manuel
    Ferrer Rosique, Juan
    Varela Trastoy, Pilar
    Nunez, Alejandro
    Ricart, Elena
    Riestra, Sabino
    Arias Garcia, Lara
    Rodriguez, Maria
    Arranz, Laura
    Pajares, Ramon
    Mena, Raquel
    Calafat, Margalida
    Camo, Patricia
    Bermejo, Fernando
    Ponferrada, Angel
    Eva Madrigal, Rosa
    Llao, Jordina
    Sese, Eva
    Sanchez, Eugenia
    Pineda Marino, Juan Ramon
    Gonzalez Munoza, Carlos
    Carbajo Lopez, Ana Yaiza
    Belen Julian, Ana
    Villoria Ferrer, Albert
    Baston-Rey, Iria
    Jara, Lorena
    Almela, Pedro
    Codesido, Laura
    de la Maza, Saioa
    Leal, Carles
    Caballol, Berta
    Perez-Martinez, Isabel
    Vinuesa Campo, Raquel
    Crespo, Javier
    Domenech, Eugeni
    Chaparro, Maria
    Gisbert, Javier P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 65 - 74
  • [32] Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn's disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry
    Biemans, V.
    van der Woude, J.
    Dijkstra, G.
    van der Meulen-de Jong, A.
    Lowenberg, M.
    de Boer, N.
    Oldenburg, B.
    Srivastava, N.
    Jansen, J.
    Bodelier, A.
    West, R.
    de Vries, A.
    Haans, J.
    de Jong, D.
    Hoentjen, F.
    Pierik, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S114 - S116
  • [33] Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment
    Biemans, Vince B. C.
    van der Woude, C. Janneke
    Dijkstra, Gerard
    van der Meulen-de Jong, Andrea E.
    Lowenberg, Mark
    de Boer, Nanne K.
    Oldenburg, Bas
    Srivastava, Nidhi
    Jansen, Jeroen M.
    Bodelier, Alexander G. L.
    West, Rachel L.
    de Vries, Annemarie C.
    Haans, Jeoffrey J. L.
    de Jong, Dirk
    Hoentjen, Frank
    Pierik, Marieke J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 123 - 134
  • [34] Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Adimadhyam, Sruthi
    Hou, Laura
    Simon, Andrew L.
    Dobes, Angela
    Parlett, Lauren E.
    Haynes, Kevin
    Selvan, Mano
    Ma, Qianli
    Nair, Vinit
    Burris, Jessica L.
    Dorand, Jennifer E.
    Long, Millie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S519 - S520
  • [35] WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY
    Rayer, Cassandra
    Roblin, Xavier
    Laharie, David
    Flamant, Mathurin
    Dewitte, Marie
    Fumery, Mathurin
    Caron, Benedicte
    Viennot, Stephanie
    Pariente, Benjamin
    Laurent, Siproudhis
    Peyrin-Biroulet, Laurent
    Bouguen, Guillaume
    GASTROENTEROLOGY, 2020, 158 (06) : S958 - S958
  • [36] Which second-line biologic after anti-TNF failure during Crohn's disease: Ustekinumab or vedolizumab, a multicentre retrospective study
    Rayer, C.
    Roblin, X.
    Laharie, D.
    Caron, B.
    Flamant, M.
    Dewitte, M.
    Fumery, M.
    Viennot, S.
    Bourreille, A.
    Pariente, B.
    Siproudhis, L.
    Peyrin-Biroulet, L.
    Bouguen, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S547 - S547
  • [37] Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study
    Albshesh, Ahmad
    Bannon, Lian
    Sharar Fischler, Tali
    Truyens, Marie
    Vavricka, Stephan R. R.
    Tepes, Katja
    Pugliese, Daniela
    Savarino, Edoardo V. V.
    Zittan, Eran
    Drobne, David
    Roblin, Xavier
    Bar-Gil Shitrit, Ariella
    Armuzzi, Alessandro
    Lobaton, Triana
    Maharshak, Nitsan
    Yanai, Henit
    Ben-Horin, Shomron
    Kopylov, Uri
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [38] Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail. Authors' reply
    Alric, Hadrien
    Amiot, Aurelien
    Carbonnel, Franck
    Meyer, Antoine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 563 - 564
  • [39] Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD)
    Garcia, M. J.
    Rivero, M.
    Fernandez-Clotet, A.
    de Francisco, R.
    Sicilia, B.
    Mesonero, F.
    de Castro, M. L.
    Casanova, M. J.
    Bertoletti, F.
    Garcia Alonso, F. J.
    Lopez Garcia, A.
    Julian, B.
    Calvet, X.
    Barreiro-de Acosta, M.
    Jara, L.
    Varela, P.
    Nunez, A.
    Ricart, E.
    Riestra, S.
    Arias, L.
    Rodriguez, M.
    Arranz, L.
    Pajares, R.
    Mena, R.
    Calafat, M.
    Camo, P.
    Jimenez, L.
    Ponferrada, A.
    Madrigal, R. E.
    Llao, J.
    Sese, E.
    Almela, P.
    Codesido, L.
    de la Maza, S.
    Leal, C.
    Sanchez, E.
    Pineda Marino, J. R.
    Domenech, E.
    Chaparro, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I121 - I123
  • [40] COMPARISON OF SHORT AND LONG-TERM EFFICACY BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN PATIENTS WITH CROHN'S DISEASE REFRACTORY TO ANTI-TNF THERAPY
    Manlay, Luc
    Boschetti, Gilles
    Pereira, Bruno
    Buisson, Anthony
    Nancey, Stephane
    GASTROENTEROLOGY, 2021, 160 (06) : S6 - S6
12345